MEI Pharma Investors: Company –

Investors can Contact the toll-free law firm to learn more about recovering their losses

LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) — Portnoy law firm advises investors of MEI Pharma, Inc. (MEIP) that the company has opened an investigation into possible securities fraud and may file a class action lawsuit on behalf of investors. MEI Pharma investors who have lost money on their investment are encouraged to Contact Lesley Portnoy, Esq.

Investors are encouraged to contact a lawyer Lesley F. Portnoyby phone 844-767-8529 or E-mail: [email protected]to discuss their legal rights, or Click here join the case via Portnoy Law Firm can provide a free case assessment and discuss options for investors to pursue claims to recover their losses.

On May 13, 2022, after market hours, MEI Pharma announced restatements of its financial statements for certain quarters of 2020 and 2021. In part, MEI Pharma stated: “[R]revenues were overstated in some quarters and understated in others in the Company’s financial statements in 2020 and 2021. The Company will therefore restate its previously filed annual and quarterly financial statements for periods beginning June 30, 2020. »

On this news, MEI Pharma’s stock price fell $0.0242, or 4.6%, to open at $0.4958 per share on May 16, 2022, hurting investors.

Please visit our website to review more information and submit your transaction information.

Portnoy Law Firm represents investors in the prosecution of claims caused by corporate wrongdoing. The company’s founding partner has recovered more than $5.5 billion for harmed investors. Lawyer advertisement. Prior results do not guarantee similar results.

Lesley F. Portnoy, Esq.
Admitted to the CA and NY Bar
[email protected]

Lawyer advertisement


Robert D. Coleman